SIR JONATHON BAND, a director at $CCL, sold 12,500 shares of the company on 08-05-2025 for an estimated $371,912. We received data on the trade from a recent SEC filing. This was a sale of approximately 16.3% of their shares of this class of stock. Following this trade, they now own 64,405 shares of this class of $CCL stock.
$CCL Insider Trading Activity
$CCL insiders have traded $CCL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CCL stock by insiders over the last 6 months:
- DAVID BERNSTEIN (CFO & CAO) sold 105,010 shares for an estimated $2,398,533
- SIR JONATHON BAND sold 12,500 shares for an estimated $371,912
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CCL Hedge Fund Activity
We have seen 465 institutional investors add shares of $CCL stock to their portfolio, and 412 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAUSEWAY CAPITAL MANAGEMENT LLC added 26,565,066 shares (+inf%) to their portfolio in Q1 2025, for an estimated $518,815,738
- VIKING GLOBAL INVESTORS LP added 12,408,817 shares (+inf%) to their portfolio in Q1 2025, for an estimated $242,344,196
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 11,049,652 shares (-59.2%) from their portfolio in Q1 2025, for an estimated $215,799,703
- JPMORGAN CHASE & CO added 6,177,010 shares (+37.0%) to their portfolio in Q1 2025, for an estimated $120,637,005
- FMR LLC added 5,648,167 shares (+57.1%) to their portfolio in Q1 2025, for an estimated $110,308,701
- RENAISSANCE TECHNOLOGIES LLC removed 5,271,212 shares (-29.1%) from their portfolio in Q1 2025, for an estimated $102,946,770
- POINT72 ASSET MANAGEMENT, L.P. removed 4,693,896 shares (-40.5%) from their portfolio in Q1 2025, for an estimated $91,671,788
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CCL Congressional Stock Trading
Members of Congress have traded $CCL stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $100,000 on 05/12, 04/07.
- REPRESENTATIVE SUSIE LEE sold up to $15,000 on 03/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CCL Analyst Ratings
Wall Street analysts have issued reports on $CCL in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Tigress Financial issued a "Buy" rating on 07/29/2025
- B of A Securities issued a "Buy" rating on 07/23/2025
- TD Cowen issued a "Buy" rating on 07/22/2025
- Citigroup issued a "Buy" rating on 07/16/2025
- Barclays issued a "Overweight" rating on 06/25/2025
- Susquehanna issued a "Positive" rating on 06/25/2025
- Mizuho issued a "Outperform" rating on 06/25/2025
To track analyst ratings and price targets for $CCL, check out Quiver Quantitative's $CCL forecast page.
$CCL Price Targets
Multiple analysts have issued price targets for $CCL recently. We have seen 12 analysts offer price targets for $CCL in the last 6 months, with a median target of $33.5.
Here are some recent targets:
- Ivan Feinseth from Tigress Financial set a target price of $38.0 on 07/29/2025
- Nicholas Thomas from B of A Securities set a target price of $38.0 on 07/23/2025
- Kevin Kopelman from TD Cowen set a target price of $36.0 on 07/22/2025
- Patrick Scholes from Truist Securities set a target price of $31.0 on 07/21/2025
- James Hardiman from Citigroup set a target price of $37.0 on 07/16/2025
- Jamie Rollo from Morgan Stanley set a target price of $24.0 on 06/26/2025
- Brandt Montour from Barclays set a target price of $33.0 on 06/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
